* It should be noted that Augusto S.p.A. holds an equity investment equal to 47.45% of the total share capital of Aedes SIIQ S.p.A., of which n. 13,678,083 ordinary shares (equal to 39.40% of total ordinary shares) and n. 5,316,241 special shares (equal to 100% of the total shares of this category).
** On 27 July 2020, the shareholder Augusto, in the context of updating the communication pursuant to art. 120 of the Consolidated Law on Finance following the completion of the capital increase, reserved for the subscription by Augusto, approved by the extraordinary Shareholders’ Meeting of Aedes on 18 June 2020 and executed on 24 July 2020, confirmed to the Company that Augusto is legitimate owner of additional n. 5,020,618 Aedes SIIQ SpA ordinary shares, equal to 12.54% of the total share capital of Aedes, originally deposited with an English intermediary and against which emerged, also following the outcome of legal initiatives initiated by Augusto, illegitimate disposals , in nature and in favor of recipients yet to be ascertained. In particular, Augusto has reported that he is not yet able to assess whether the aforementioned Aedes shares are deposited in other accounts that are in any case attributable to the depositary intermediary or if they have been, in whole or in part, definitively sold to third parties.
Augusto consequently communicated that at present he is unable to exercise the rights relating to the aforementioned no. 5,020,618 Aedes ordinary shares and a state of uncertainty remains regarding the recoverability of their availability. The shareholder Augusto also represented to the Company that, in the event of a positive outcome of the affair, Augusto would recover the legitimate availability of its equity investment equal to 60.89% of the total share capital of Aedes and 54.9% of the share capital represented from ordinary shares, without which an obligation to promote the takeover bid can result.